Cargando…
Does hereditary angioedema make COVID-19 worse?
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly worldwide. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for COVID-19, enters host cells via angiotensin-converting enzyme 2 (ACE2) and depletes ACE2, which is necessary for bradykinin metabolism....
Autores principales: | Xu, Yingyang, Liu, Shuang, Zhang, Yan, Zhi, Yuxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416729/ https://www.ncbi.nlm.nih.gov/pubmed/32834893 http://dx.doi.org/10.1016/j.waojou.2020.100454 |
Ejemplares similares
-
Long-term prophylaxis of hereditary angioedema with danazol
por: Xu, Yingyang, et al.
Publicado: (2022) -
Mutation update of SERPING1 related to hereditary angioedema in the Chinese population
por: Wang, Xue, et al.
Publicado: (2022) -
Health-related quality of life and its risk factors in Chinese hereditary angioedema patients
por: Liu, Shuang, et al.
Publicado: (2019) -
Validation of diagnostic and predictive biomarkers for hereditary angioedema via plasma N‐glycomics
por: Zhang, Zejian, et al.
Publicado: (2021) -
The natural course of hereditary angioedema in a Chinese cohort
por: Cao, Yang, et al.
Publicado: (2020)